rs8018687
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001040275.1(ESR2):c.*169A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0999 in 697,990 control chromosomes in the GnomAD database, including 6,727 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 3746 hom., cov: 32)
Exomes 𝑓: 0.082 ( 2981 hom. )
Consequence
ESR2
NM_001040275.1 3_prime_UTR
NM_001040275.1 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0130
Genes affected
ESR2 (HGNC:3468): (estrogen receptor 2) This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 14-64227364-T-C is Benign according to our data. Variant chr14-64227364-T-C is described in ClinVar as [Benign]. Clinvar id is 1237589.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESR2 | NM_001040275.1 | c.*169A>G | 3_prime_UTR_variant | Exon 9 of 9 | NP_001035365.1 | |||
ESR2 | NM_001291712.2 | c.*169A>G | 3_prime_UTR_variant | Exon 14 of 14 | NP_001278641.1 | |||
ESR2 | NM_001291723.1 | c.*169A>G | 3_prime_UTR_variant | Exon 9 of 9 | NP_001278652.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESR2 | ENST00000353772 | c.*169A>G | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000335551.4 | ||||
ESR2 | ENST00000554572 | c.*169A>G | 3_prime_UTR_variant | Exon 14 of 14 | 1 | ENSP00000450699.1 | ||||
ESR2 | ENST00000556275.5 | c.1406+7606A>G | intron_variant | Intron 8 of 8 | 2 | ENSP00000452485.2 |
Frequencies
GnomAD3 genomes AF: 0.165 AC: 25085AN: 152104Hom.: 3739 Cov.: 32
GnomAD3 genomes
AF:
AC:
25085
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0817 AC: 44581AN: 545768Hom.: 2981 Cov.: 7 AF XY: 0.0835 AC XY: 23823AN XY: 285240
GnomAD4 exome
AF:
AC:
44581
AN:
545768
Hom.:
Cov.:
7
AF XY:
AC XY:
23823
AN XY:
285240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.165 AC: 25131AN: 152222Hom.: 3746 Cov.: 32 AF XY: 0.162 AC XY: 12064AN XY: 74424
GnomAD4 genome
AF:
AC:
25131
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
12064
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
435
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jul 09, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at